SIEMENS HEALTH.AG NA O.N.
Commented by Nico Popp on September 4th, 2025 | 07:25 CEST
AI reaches medicine – Here is where it has the greatest impact: NetraMark, Siemens Healthineers, Intuitive Surgical
AI is revolutionizing more and more industries. A recent article in Handelsblatt highlights the enormous potential in medicine and names Siemens Healthineers and Intuitive Surgical as the beneficiaries. AI would significantly increase the often-lacking efficiency in industry. According to Handelsblatt, citing analysts from Fortune Business Insights, the market for AI in healthcare could grow by 44% annually to USD 504 billion by 2032. We show where the greatest leverage exists and which companies are still small enough to benefit disproportionately from developments in the coming years.
Read
Commented by Nico Popp on July 24th, 2025 | 07:10 CEST
No high-tech without tungsten – This bottleneck brings returns: Almonty, Siemens Healthineers, Intel
Tungsten is known as a defense metal due to its hardness and heat resistance. But it is also one of the invisible drivers of the high-tech industry. Using examples from medical technology and chip manufacturing, we explain why tungsten is rightly considered a key element in the future of raw material supply. We also venture a long-term outlook on the potential of tungsten producer Almonty Industries' stock.
Read
Commented by Nico Popp on July 17th, 2025 | 07:15 CEST
Silver becomes a defense metal: Silver North, Rheinmetall, Siemens Healthineers
US President Donald Trump's ultimatum to Russia is less than four days old, and it is already clear that it will go unanswered. Russia is continuing its attacks on Ukraine and shows no signs of backing down. At the same time, the defense industry is continually striking new deals, expanding capacity, and investing in innovation. Many of these innovations require silver. We explain the surge in demand for this precious and industrial metal and highlight investment opportunities.
Read
Commented by Nico Popp on May 28th, 2025 | 06:55 CEST
Smart innovations for strong returns: BioNTech, BioNxt Solutions, and Siemens Healthineers
For a new drug to hit the market, it has to outperform existing alternatives – so innovation is key for biotech companies. In medical technology, too, innovations must first and foremost benefit patients. However, research and development are expensive. We analyze how BioNTech, BioNxt Solutions, and Siemens Healthineers are driving innovation and what that means for investors.
Read
Commented by Stefan Feulner on August 28th, 2024 | 07:15 CEST
Siemens Healthineers, Vidac Pharma, Viking Therapeutics - Powerful movements
After the hype during the COVID-19 pandemic, biotech stocks have lagged behind the broader market, allowing major technology companies to take the lead. Smaller, capital-intensive companies, in particular, have suffered from the high interest rate level. However, this is likely to change soon. On the one hand, monetary policy is expected to be eased, and on the other hand, demographic changes point to a long-term explosion in demand for new medications.
Read
Commented by Nico Popp on June 15th, 2023 | 08:55 CEST
Breakthrough for the e-truck? Daimler Truck, Siemens Healthineers, Almonty Industries
For a long time, hydrogen was considered the energy carrier for heavy machinery. Now Daimler Truck has high hopes for a battery-powered model of its Actros. We explain the background, shed light on what lies behind Siemens Healthineers' share buyback program and also introduce a company that could benefit equally from advances in medical technology and the run on modern batteries.
Read
Commented by André Will-Laudien on April 6th, 2022 | 10:46 CEST
Siemens Healthineers, Perimeter Medical, Siemens, SAP - After BioNTech, now the push for MedTech shares!
The most significant positive share price developments in the last 12 months occurred in the biotech sector, especially among vaccine manufacturers such as BioNTech and Moderna. The stock market overlooked that pandemics, and the fight against them, offer short-term profit opportunities. The great battle against widespread diseases such as cardiovascular disease, cancer or other previously incurable indications progresses steadily. Their diagnosis and treatment require many types of technology, devices, processes, analysis tools, and intelligent software. Some methods certainly deserve the attribute "disruptive technology". We take a look at some blockbusters in the MedTech segment.
Read
Commented by André Will-Laudien on February 15th, 2022 | 12:30 CET
Attention: Siemens Healthineers, Perimeter Medical Imaging AI, MorphoSys, Siemens - Riding the next hype with MedTech!
MedTech and pharma giants have been in high demand not only since the pandemic. The technification of diagnostics leads to the early detection of serious diseases and shortens the planning of necessary medical interventions. Of course, COVID-19 significantly impacts the availability and additional demand for high-tech in practices and emergency departments. It is creating a boom in demand from manufacturers rarely seen at this headline rate. We are looking at clear winners in medical digitization.
Read
Commented by Armin Schulz on February 7th, 2022 | 12:14 CET
Bayer, Perimeter Medical Imaging AI, Siemens Healthineers - Diagnostics as an upcoming trend in the pharmaceutical industry
The Corona pandemic has made many people aware of the importance of diagnostics. Without PCR and antigen tests, it would have been impossible to control the incidence of infection. But it is not only in this area that things have changed in the last 2 years. Diagnostics are becoming increasingly digitized, and so more and more tech companies are entering the market that originally had nothing to do with the pharmaceutical industry. The better the diagnostics, the earlier diseases can be detected and treated. It is a future topic in pharma. We look at three companies from this sector today.
Read
Commented by Nico Popp on January 31st, 2022 | 11:56 CET
MedTech with billion-dollar potential: Siemens Healthineers, Perimeter Medical Imaging, Sartorius
When we think of medical technology, we often think of the big players like Siemens Healthineers or the Fresenius Group. But the MedTech sector is characterized mainly by small and medium-sized companies. This is shown by a survey conducted by the German Medical Technology Association (BVMed). The experts have seen rising sales for years in this very diverse sector. Reason enough to shed light on a promising market from an investor's perspective. We present three companies and their shares.
Read